Nectar Willeshave P/S: Financial statements 2022
CVR: 41735821
Source: annual report 2022, Danish Business Authority
01/02/2022 – 31/12/2022
Nectar Willeshave P/S (CVR 41735821) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 267,171 and a net result of DKK 8,877,585. Equity in the 2022 report amounted to DKK 27,090,321. The solvency ratio was 27.9%.
- Gross Profit
- DKK 267,171
- Profit/Loss
- DKK 8,877,585
- Equity
- DKK 27,090,321
- Total Assets
- DKK 96,979,418
- Employees
- 0
Official annual report
Keep an eye on Nectar Willeshave P/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of November 4, 2022, Bjørk Krogshave has joined the board of directors of Nectar Willeshave P/S.
As of November 4, 2022, Peer Thomas Borg has joined the board of directors of Nectar Willeshave P/S.
As of November 4, 2022, Tommas Jakobsen has joined the board of directors of Nectar Willeshave P/S.
As of November 4, 2022, Niels Christian Thorbjørn Olsen has left the board of directors of Nectar Willeshave P/S.
As of November 4, 2022, Vivi Sørensen has left the board of directors of Nectar Willeshave P/S.
As of November 4, 2022, Robert Andersen has left the board of directors of Nectar Willeshave P/S.
As of November 4, 2022, Bjørk Krogshave is registered as director of Nectar Willeshave P/S.
As of November 4, 2022, Vivi Sørensen has stepped down as director of Nectar Willeshave P/S.
Nectar Willeshave P/S has published its interim report for the period September 30, 2020 – January 31, 2022.
As of May 4, 2022, Niels Christian Thorbjørn Olsen has joined the board of directors of Nectar Willeshave P/S.
About Nectar Willeshave P/S
Nectar Willeshave P/S is a Danish company of the type Kommanditaktieselskab/Partnerselskab based in København K, founded in 2020. The company is registered under the industry Gennemførelse af byggeprojekter. The company was previously named PROJEKTSELSKABET KØGE B11/B12 P/S. The management consists of Bjørk Krogshave. The board consists of Peer Thomas Borg (chair), Bjørk Krogshave and Peter Graversen. The company is owned by PharmaService I/S and Nectar Invest A/S. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 3,642,887 and a net result of DKK 3,130,361 compared with DKK 1,065,152 the year before. Equity in the 2025 report amounted to DKK 31,391,132.